Lorena Incorvaia

3.8k total citations
113 papers, 1.9k citations indexed

About

Lorena Incorvaia is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Lorena Incorvaia has authored 113 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 56 papers in Pulmonary and Respiratory Medicine and 32 papers in Cancer Research. Recurrent topics in Lorena Incorvaia's work include Cancer Genomics and Diagnostics (22 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Renal cell carcinoma treatment (15 papers). Lorena Incorvaia is often cited by papers focused on Cancer Genomics and Diagnostics (22 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Renal cell carcinoma treatment (15 papers). Lorena Incorvaia collaborates with scholars based in Italy, France and United States. Lorena Incorvaia's co-authors include Antonio Russo, Giuseppe Badalamenti, Viviana Bazan, Daniele Fanale, Angela Listì, Antonio Galvano, Nadia Barraco, Juan Iovanna, Valentina Calò and Gaetano Leto and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Lorena Incorvaia

104 papers receiving 1.9k citations

Peers

Countries citing papers authored by Lorena Incorvaia

Since Specialization

Citations

This map shows the geographic impact of Lorena Incorvaia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorena Incorvaia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorena Incorvaia more than expected).

Fields of papers citing papers by Lorena Incorvaia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorena Incorvaia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorena Incorvaia. The network helps show where Lorena Incorvaia may publish in the future.

Co-authorship network of co-authors of Lorena Incorvaia

This figure shows the co-authorship network connecting the top 25 collaborators of Lorena Incorvaia. A scholar is included among the top collaborators of Lorena Incorvaia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorena Incorvaia. Lorena Incorvaia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-life Use of Cabozantinib in Front-line therapy for Metastatic Renal Cell Carcinoma: The CabFRONT Study (Meet-URO 24) 2025 ·European Urology Open Science ·Marco Stellato, Pierangela Sepe, Enrico Bronte, Vincenza Conteduca, Maria Cossu Rocca, Ugo De Giorgi, Marilena Di Napoli, Luca Galli, Lorena Incorvaia, Luca Lalli, Brigida Anna Maiorano, Marco Maruzzo, Alessia Mennitto, Giandomenico Roviello, Matteo Santoni, Mariella Sorarů, Elisa Zanardi, Paolo Andrea Zucali, Giuseppe Procopio, Elena Verzoni	0
2	BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study 2025 ·ESMO Open ·Lorena Incorvaia, Cláudia Marchetti, Chiara Brando, Tancredi Didier Bazan Russo, Marco Bono, Alessandro Perez, (unknown), (unknown), (unknown), Lavinia Insalaco, (unknown), Valerio Gristina, Antonio Galvano, Daniele Fanale, Giuseppe Badalamenti, Antonio Russo, Giovanni Scambia, Viviana Bazan	2
3	The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors 2024 ·npj Precision Oncology ·Lorena Incorvaia, Tancredi Didier Bazan Russo, Valerio Gristina, Alessandro Perez, Chiara Brando, (unknown), (unknown), Marco Bono, (unknown), (unknown), (unknown), (unknown), Marta Peri, Antonio Galvano, Daniele Fanale, Giuseppe Badalamenti, (unknown), Viviana Bazan	10
4	Applications of Platelet Concentrates (PCs) in Regenerative Onco-Urology: A Systematic Review of Literature 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), Nicola Pavan, Fabio Fulfaro, Valerio Gristina, Tancredi Didier Bazan Russo, (unknown), Francesco Claps, Lorena Incorvaia, Antonio Galvano, Antonio Russo, Alchiede Simonato	0
5	42P Efficacy of maintenance with PARPi in advanced ovarian cancer according to the location of BRCA mutation 2023 ·ESMO Open ·(unknown), Anna Fagotti, Chiara Cassani, Lorena Incorvaia, Maria Teresa Perri, (unknown), (unknown), Elena Giudice, Angelo Minucci, Eloisa Arbustini, Laura Vertechy, (unknown), (unknown), Serena Maria Boccia, Lucia Musacchio, Gabriella Ferrandina, Andrea Russo, Giovanni Scambia, Domenica Lorusso	1
6	Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis 2023 ·Diagnostics ·(unknown), Marta Peri, Giuseppe Roberto Giammalva, Antonino Lupica, Federica Paolini, Lorena Incorvaia, Giuseppe Badalamenti, Valerio Gristina, Antonio Galvano, Antonio Russo, Domenico Gerardo Iacopino, Mauro Silvestrini, Viviana Bazan, Filippo Brighina, Vincenzo Di Stefano	5
7	Real life use of biomarkers of homologous recombination deficiency (HRD) status beyond BRCA to predict the effectiveness of PARP inhibitors in ovarian cancer patients. 2023 ·Journal of Clinical Oncology ·Lorena Incorvaia, Chiara Brando, Alessandro Perez, Marco Bono, (unknown), (unknown), Nadia Barraco, (unknown), (unknown), Anna Paola Carreca, Valerio Gristina, Antonio Galvano, Tancredi Didier Bazan Russo, (unknown), Lavinia Insalaco, Daniele Fanale, Cláudia Marchetti, Viviana Bazan, Antonio Russo, Ignazio Carreca	0
8	Chemotherapy-related cardiac dysfunction: the usefulness of myocardial work indices 2023 ·The International Journal of Cardiovascular Imaging ·Daniela Di Lisi, (unknown), Cristina Madaudo, Clarissa Filorizzo, (unknown), Alfredo R. Galassi, Lorena Incorvaia, Antonio Russo, Giuseppina Novo	11
9	Mapping the landscape of immunonutrition and cancer research: a comprehensive bibliometric analysis on behalf of NutriOnc Research Group 2023 ·International Journal of Surgery ·Francesca De Felice, (unknown), (unknown), Carmine Antropoli, Antonio Brillantino, L. Carbone, Oronzo Brunetti, Raffaele De Luca, Isacco Desideri, Lorena Incorvaia, (unknown), Federica Marmorino, Dario Parini, Maria Grazia Rodriquenz, Viola Salvestrini, Federica Sebastiani, Karol Połom, Luigi Marano	13
10	Statin use improves the efficacy of nivolumab in patients with advanced renal cell carcinoma 2022 ·European Journal of Cancer ·Matteo Santoni, Francesco Massari, Marc Matrana, Umberto Basso, Ugo De Giorgi, Gaetano Aurilio, Sebastiano Buti, Lorena Incorvaia, Mimma Rizzo, Angelo Martignetti, (unknown), (unknown), (unknown), Zoë Blake, Camillo Porta, Nicola Battelli	15
11	Deep Learning Networks for Automatic Retroperitoneal Sarcoma Segmentation in Computerized Tomography 2022 ·Applied Sciences ·Giuseppe Salvaggio, (unknown), (unknown), (unknown), L Salvaggio, Federica Vernuccio, Roberto Cannella, (unknown), Lorena Incorvaia, Alessandro Stefano, Massimo Galia, Giuseppe Badalamenti, Albert Comelli	8
12	Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors 2021 ·Critical Reviews in Oncology/Hematology ·Lorena Incorvaia, (unknown), Lidia Rita Corsini, (unknown), Chiara Brando, Cesare Gagliardo, Matteo Santoni, Daniele Fanale, Alessandro Inno, (unknown), Giovanni Foti, Massimo Galia, Giuseppe Badalamenti, Viviana Bazan, Antonio Russo, Stefania Gori	5
13	Type and Gene Location of KIT Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon 2021 ·Cancers ·Lorena Incorvaia, Daniele Fanale, Bruno Vincenzi, (unknown), Tommaso Vincenzo Bartolotta, Roberto Cannella, Gianni Pantuso, Daniela Cabibi, Antonio Russo, Viviana Bazan, Giuseppe Badalamenti	8
14	Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival? 2021 ·Cancers ·Daniele Fanale, Lorena Incorvaia, Giuseppe Badalamenti, (unknown), (unknown), (unknown), Lidia Rita Corsini, Chiara Brando, Antonio Russo, Juan Iovanna, Viviana Bazan	20
15	A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming 2020 ·Cancers ·Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, Chiara Brando, Marco Bono, (unknown), (unknown), (unknown), Lidia Rita Corsini, (unknown), Juan Iovanna, Antonio Russo, Viviana Bazan	31
16	Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions 2020 ·OncoImmunology ·Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, Camillo Porta, Daniel Olive, (unknown), Chiara Brando, Mimma Rizzo, Carlo Messina, Mattia Rediti, Antonio Russo, Viviana Bazan, Juan Iovanna	55
17	Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)—Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes 2020 ·Cancers ·Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, Marco Bono, Valentina Calò, (unknown), Marta Castiglia, Alessia Fiorino, (unknown), Nadia Barraco, (unknown), Antonio Russo, Viviana Bazan	24
18	Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2 2020 ·Cancers ·Daniele Fanale, Lorena Incorvaia, Clarissa Filorizzo, Marco Bono, Alessia Fiorino, Valentina Calò, Chiara Brando, Lidia Rita Corsini, Nadia Barraco, Giuseppe Badalamenti, Antonio Russo, Viviana Bazan	35
19	Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1 2019 ·Journal of Oncology ·Giuseppe Badalamenti, Nadia Barraco, Lorena Incorvaia, Antonio Galvano, Daniele Fanale, Daniela Cabibi, Valentina Calò, Giuseppe Currò, Viviana Bazan, Antonio Russo	12
20	Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone? 2018 ·Cellular Immunology ·Giuseppe Badalamenti, Daniele Fanale, Lorena Incorvaia, Nadia Barraco, Angela Listì, R. Maragliano, Bruno Vincenzi, Valentina Calò, Juan Iovanna, Viviana Bazan, Antonio Russo	167

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact